Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/06/24/2903359/0/en/Corcept-Announces-Presentation-of-Results-From-Prevalence-Phase-of-CATALYST-Clinical-Trial-at-American-Diabetes-Association-s-Scientific-Sessions.html
https://www.reuters.com/legal/teva-sues-corcept-over-mifepristone-monopoly-rare-disorder-2024-06-13/
https://www.globenewswire.com/news-release/2024/06/03/2892174/0/en/Corcept-Therapeutics-Announces-Presentations-of-Results-of-Pivotal-Phase-3-GRACE-Trial-Evaluating-Relacorilant-in-Patients-with-Hypercortisolism-Cushing-s-Syndrome.html
https://www.globenewswire.com/news-release/2024/05/28/2888977/0/en/Corcept-Announces-Primary-Endpoint-Met-in-Pivotal-Phase-3-GRACE-Trial-of-Relacorilant-in-Patients-With-Hypercortisolism-Cushing-s-Syndrome.html
https://www.globenewswire.com/news-release/2024/05/01/2873605/0/en/Corcept-Therapeutics-Announces-First-Quarter-Financial-Results-and-Provides-Corporate-Update.html
https://www.globenewswire.com/news-release/2024/04/29/2871197/0/en/Corcept-Completes-Enrollment-in-Phase-4-CATALYST-Trial.html
https://www.globenewswire.com/news-release/2024/04/24/2869057/0/en/Corcept-Therapeutics-to-Announce-First-Quarter-Financial-Results-Provide-Corporate-Update-and-Host-Conference-Call.html
https://www.globenewswire.com/news-release/2024/04/22/2866811/0/en/Corcept-Announces-Positive-Results-From-Open-Label-Portion-of-Pivotal-Phase-3-GRACE-Trial-in-Patients-With-Cushing-s-Syndrome.html
https://www.globenewswire.com/news-release/2024/04/15/2862710/0/en/Corcept-Completes-Enrollment-in-Phase-2-DAZALS-Trial-in-Patients-With-Amyotrophic-Lateral-Sclerosis-ALS.html
https://www.globenewswire.com/news-release/2024/04/08/2859131/0/en/Corcept-Completes-Enrollment-in-Pivotal-Phase-3-Rosella-Trial-of-Relacorilant-in-Patients-With-Platinum-Resistant-Ovarian-Cancer.html